+34 93 402 04 56 info@proteodesign.es

About ProteoDesign

We develop breakthrough technologies to create the next generation of protein-based medicines

About 1
About 2
About 3

ProteoDesign, founded in 2012 as a spin-off from Princeton University, is currently based in the Barcelona Science Park and is committed to the development of new generation of protein therapeutics using proprietary conjugation technologies

ProteoDesign’s technology enables the development and production of a superior class of biotherapeutics, including antibody-drug conjugates, overcoming limitations of currently used methods.

Our Mission

Our mission is to improve patients’ quality of life by using our technological platform to develop novel biotherapeutics that deliver a superior efficacy with reduced side-effects.

Our commitments

  • To contribute our scientific knowledge and expertise to the development of the biotechnological community
  • To stimulate the continued improvement of the quality of our products and activities in order to provide real and consistent value to our partners, customers and end users.
  • To offer an excellent service package that adds value and satisfies our global clients’ standards and demands.
  • To identify interesting work opportunities in which ProteoDesign team members can professionally develop.

Our values

Professionalism, personal commitment, teamwork, individual progression, high level of training, innovation and creativity, efficiency, agility and integrity.